SCHEMBL23879060

SCHEMBL23879060

Cc1cc(Nc2nc(NC3CC4CCC(C3)N4C(=O)CN(C)C)nc3sccc23)n[nH]1

nearest known ligand 0.57

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 14/20 0.57
▸ TYK2 P29597 13/20 0.57
▸ JAK3 P52333 13/20 0.57
▸ JAK1 P23458 11/20 0.57
▸ PAK4 O96013 4/20 0.42
▸ PLK4 O00444 2/20 0.42
▸ BRD4 O60885 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22055383 1.00 JAK2 (0.57) JAK2TYK2JAK3JAK1PAK4
SCHEMBL23878782 0.97 JAK3 (0.61) JAK2TYK2JAK3JAK1PAK4
SCHEMBL22054962 0.97 JAK3 (0.61) JAK2TYK2JAK3JAK1PAK4
SCHEMBL23889628 0.90 JAK2 (0.47) JAK2TYK2JAK3JAK1PAK4
SCHEMBL23889625 0.90 JAK2 (0.47) JAK2TYK2JAK3JAK1PAK4
SCHEMBL22054611 0.90 TYK2 (0.46) JAK2TYK2JAK3JAK1PAK4
SCHEMBL22054610 0.90 TYK2 (0.46) JAK2TYK2JAK3JAK1PAK4
SCHEMBL23878876 0.89 JAK2 (0.46) JAK2TYK2JAK3JAK1PAK4
SCHEMBL30147204 0.89 TYK2 (0.48) JAK2TYK2JAK3JAK1PAK4
SCHEMBL22055075 0.88 TYK2 (0.44) JAK2TYK2JAK3JAK1PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115667228-A Salt and crystal form of heteroaromatic derivative and preparation method of salt and crystal form 上海翰森生物医药科技有限公司 2023-01-31 — — CN disclosed
CN-111511738-B Heteroaromatic derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2023-01-20 — — CN disclosed
EP-3889152-A1 HETEROAROMATIC DERIVATIVES FOR USE AS REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2021-10-06 — — EP disclosed
Send feedback